Other Species / Isoforms
  RARA (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S74
SSEEIVPSPPsPPPL
1 0
RARA (human) SSEEIVPsPPsPPPL S74-p
RARA iso2 (human) SSEEIVPSPPsPPPL S69
RARA (mouse) SSEEIVPSPPsPPPL S74
RARA (rat) SSEEIVPSPPSPPPL S71
S77-p
EIVPSPPsPPPLPRI
Upstream
Downstream
10 2
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • CDK1 (human)
  • CDK7 (human)
Putative in vivo kinases:
  • CDK7 (human)
RARA (human) EIVPsPPsPPPLPRI S77-p
RARA iso2 (human) EIVPSPPsPPPLPRI S72-p
RARA (mouse) EIVPSPPsPPPLPRI S77-p
RARA (rat) EIVPSPPSPPPLPRI S74
S96
FVCQDKSSGYHYGVS
1 0
RARA (human) FVCQDKSsGYHYGVS S96-p
RARA iso2 (human) FVCQDKSSGYHYGVS S91
RARA (mouse) FVCQDKSSGYHYGVS S96
RARA (rat) FVCQDKSSGYHYGVS S93
K109-me
VSACEGCkGFFRRSI
1 0
RARA (human) VSACEGCKGFFRRSI K109
RARA iso2 (human) VSACEGCKGFFRRSI K104
RARA (mouse) VSACEGCkGFFRRSI K109-me
RARA (rat) VSACEGCKGFFRRSI K106
K166
RNDRNKKKKEAPkPE
1 0
RARA (human) RNDRNKKkKEVPkPE K166-sm
RARA iso2 (human) RNDRNKKKKEVPKPE K161
RARA (mouse) RNDRNKKKKEAPkPE K166
RARA (rat) RNDRNKKKKETPKPE K163
K171-me
KKKKEAPkPECSESy
1 0
RARA (human) KKkKEVPKPECSESY K171
RARA iso2 (human) KKKKEVPKPECSESY K166
RARA (mouse) KKKKEAPkPECSESy K171-me
RARA (rat) KKKKETPKPECSESY K168
K171
KKKKEAPKPECSESy
1 0
RARA (human) KKkKEVPkPECSESY K171-sm
RARA iso2 (human) KKKKEVPKPECSESY K166
RARA (mouse) KKKKEAPKPECSESy K171
RARA (rat) KKKKETPKPECSESY K168
Y178-p
kPECSESyTLTPEVG
0 1
RARA (human) kPECSESYTLtPEVG Y178
RARA iso2 (human) KPECSESYTLTPEVG Y173
RARA (mouse) kPECSESyTLTPEVG Y178-p
RARA (rat) KPECSESYTLTPEVG Y175
T181
CSESyTLTPEVGELI
2 0
RARA (human) CSESYTLtPEVGELI T181-p
RARA iso2 (human) CSESYTLTPEVGELI T176
RARA (mouse) CSESyTLTPEVGELI T181
RARA (rat) CSESYTLTPEVGELI T178
K190
EVGELIEKVRKAHQE
0 1
RARA (human) EVGELIEkVRKAHQE K190-ub
RARA iso2 (human) EVGELIEKVRKAHQE K185
RARA (mouse) EVGELIEKVRKAHQE K190
RARA (rat) EVGELIEKVRKAHQE K187
S219
NSSEQRVSLDIDLWD
1 0
RARA (human) NSSEQRVsLDIDLWD S219-p
RARA iso2 (human) NSSEQRVSLDIDLWD S214
RARA (mouse) NSSEQRVSLDIDLWD S219
RARA (rat) NSSEQRVSLDIDLWD S216
K347-m3
QDLEQPDkVDMLQEP
2 0
RARA (human) QDLEQPDRVDMLQEP R347
RARA iso2 (human) QDLEQPDRVDMLQEP R342
RARA (mouse) QDLEQPDkVDMLQEP K347-m3
RARA (rat) QDLEQPDKVDMLQEP K344
S369-p
YVRKRRPsRPHMFPK
Upstream
Downstream
8 0
Effects on Modified Protein
  • activity, induced
  • protein degradation
Kinase, in vitro:
  • PKACA (mouse)
Putative in vivo kinases:
  • PKACA (mouse)
Treatment
  • As2O3
  • colforsin
  • retinoic_acid
RARA (human) YVRKRRPsRPHMFPK S369-p
RARA iso2 (human) YVRKRRPSRPHMFPK S364
RARA (mouse) YVRKRRPsRPHMFPK S369-p
RARA (rat) YVRKRRPSRPHMFPK S366
K399
AERVITLKMEIPGSM
1 0
RARA (human) AERVITLkMEIPGsM K399-sm
RARA iso2 (human) AERVITLKMEIPGSM K394
RARA (mouse) AERVITLKMEIPGSM K399
RARA (rat) AERVITLKMEIPGSM K396
S405
LKMEIPGSMPPLIQE
0 1
RARA (human) LkMEIPGsMPPLIQE S405-p
RARA iso2 (human) LKMEIPGSMPPLIQE S400
RARA (mouse) LKMEIPGSMPPLIQE S405
RARA (rat) LKMEIPGSMPPLIQE S402
S445-p
APPPGSCsPSLsPSS
3 2
RARA (human) APPPGSCsPSLSPSS S445-p
RARA iso2 (human) APPPGSCSPSLSPSS S440
RARA (mouse) APPPGSCsPSLsPSS S445-p
RARA (rat) APPPGSCSPSLSPSS S442
S449-p
GSCsPSLsPSSHRSs
1 0
RARA (human) GSCsPSLSPSSNRSS S449
RARA iso2 (human) GSCSPSLSPSSNRSS S444
RARA (mouse) GSCsPSLsPSSHRSs S449-p
RARA (rat) GSCSPSLSPSSHRSS S446
S456-p
sPSSHRSsPATQsP_
1 0
RARA (human) SPSSNRSSPATHsP_ S456
RARA iso2 (human) SPSSNRSSPATHSP_ S451
RARA (mouse) sPSSHRSsPATQsP_ S456-p
RARA (rat) SPSSHRSSPATQSP_ S453
S461-p
RSsPATQsP______
Upstream
3 0
Kinase, in vitro:
  • CDK1 (human)
  • CDK7 (human)
RARA (human) RSSPATHsP______ S461-p
RARA iso2 (human) RSSPATHSP______ S456
RARA (mouse) RSsPATQsP______ S461-p
RARA (rat) RSSPATQSP______ S458